← Back to Search

Pharmacogenetic Testing

Pharmacogenetic Testing for Mental Health Disorders in Kids(PGx-SParK Trial)

N/A
Recruiting
Led By Chad Bousman, PhD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
The initiation, change, dose adjustment, or augmentation of psychiatric medication(s) is indicated
Be younger than 65 years old
Must not have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up6-months
Awards & highlights
No Placebo-Only Group

PGx-SParK Trial Summary

This trial tests whether using genetic information can help tailor psychiatric medication to individual children and adolescents.

PGx-SParK Trial Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
Select...
You need to start, change, or increase the dose of your psychiatric medication.

PGx-SParK Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse drug reactions
Symptom severity
Secondary outcome measures
Healthcare utilization

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

PGx-SParK Trial Design

1Treatment groups
Experimental Treatment
Group I: Pharmacogenetic TestingExperimental Treatment1 Intervention
Pharmacogenetic testing panel (CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP3A5, NUDT15, SLCO1B1, TPMT, VKORC1)

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
755 Previous Clinical Trials
1,083,843 Total Patients Enrolled
Chad Bousman, PhDPrincipal InvestigatorUniversity of Calgary
2 Previous Clinical Trials
572 Total Patients Enrolled

Media Library

Pharmacogenetic Testing (Pharmacogenetic Testing) Clinical Trial Eligibility Overview. Trial Name: NCT04797364 — N/A
Mental Health Disorder Research Study Groups: Pharmacogenetic Testing
Mental Health Disorder Clinical Trial 2023: Pharmacogenetic Testing Highlights & Side Effects. Trial Name: NCT04797364 — N/A
Pharmacogenetic Testing (Pharmacogenetic Testing) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04797364 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals who exceed the age of 35 years permitted to participate in this experiment?

"This trial's parameters dictate that those enrolling are aged 6 to 24. There are also specialized clinical trials for patients under 18 and above 65 years old, with 6 studies dedicated to the former and 5 devoted to the latter demographic."

Answered by AI

Which individuals are the most suitable candidates for participating in this experiment?

"The researchers of this clinical trial are searching for a pool of 6000 individuals aged between 6 and 24 who suffer from mental health issues. Furthermore, the necessary qualifications to be included as a participant include: accessible medical records, an Alberta or British Columbia licensed family physician/psychiatrist/pediatrician requesting pharmacogenetic testing; indications that psychiatric medications need to commence, change dose or augment treatment regimens."

Answered by AI

What is the aggregate number of individuals participating in this research?

"Affirmative. The clinical trial database confirms that this investigation is actively looking for participants, beginning from the 18th of January 2021 and last updated on 3rd November 2022. In total, 6000 patients are sought at a single institution."

Answered by AI

Are any new participants being sought for this clinical research endeavor?

"Affirmative. According to clinicaltrials.gov, this medical trial was initially posted on January 18th 2021 and is currently in search of 6000 individuals from a single site. It has been most recently updated on November 3rd 2022."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Pharmacogenetic Supported Prescribing in Kids
Chad Bousman 2021. "Pharmacogenetic Supported Prescribing in Kids". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04797364.
~2151 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top